Randomized controlled trials in psychiatry. Part II: their relationship to clinical practice

References

• Sackett D L, Rosenberg W M.C, Gray J A.M, Haynes R B, Richardson W S. Evidence based medicine: what it is and what it isn't. It's about integrating individual clinical expertise and the best external evidence. British Medical Journal 1996; 312: 71–72
   PubMed Web of Science ®Google Scholar
• Hotopf M., Churchill R., Lewis G. Pragmatic randomised controlled trials in psychiatry. British Journal of Psychiatry 1999; 175: 217–223
   PubMed Web of Science ®Google Scholar
• Wells K B. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. American Journal of Psychiatry 1999; 156: 5–10
   PubMed Web of Science ®Google Scholar
• Ablon J S, Jones E E. Validity of controlled clinical trials of psychotherapy: findings from the NIMH treatment of depression collaborative research program. American Journal of Psychiatry 2002; 159: 775–783
   PubMed Web of Science ®Google Scholar
• Elkin I., Shea M., Watkins J., et al. National institute of mental health treatment of depression collaborative research program: general effectiveness of treatments. Archives of General Psychiatry 1989; 46: 971–982
   PubMed Web of Science ®Google Scholar
• ISIS-1 Collaborative Group. Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction. First International Study of Infarct Survival. Lancet 1986; 2: 57–66
   PubMed Web of Science ®Google Scholar
• Hotopf M., Lewis G., Normand C. Putting trials on trial –the costs and consequences of small trials in depression: a systematic review of methodology. Journal of Epidemiology and Community Health 1997; 51: 354–358
   PubMed Web of Science ®Google Scholar
• Leber P. Not in our methods, but in our ignorance. Archives of General Psychiatry 2002; 59: 279–280
   PubMed Web of Science ®Google Scholar
• Lima M S, Moncrieff J. Drugs versus placebo for the treatment of dysthymia. Cochrane Database of Systematic Reviews 2000, CD001130 (2000)
   Google Scholar
• Mattocks K M, Horwitz R I. Placebos, active control groups, and the unpredictability paradox. Biological Psychiatry 2000; 47: 693–698
   PubMed Web of Science ®Google Scholar
• Rush A J. The use of placebos in unipolar major depression: the current status. Biological Psychiatry 2000; 47: 745–747
   PubMed Web of Science ®Google Scholar
• Walsh B T, Seidman S N, Sysko R., Gould M. Placebo response in studies of major depression. Variable, substantial, and growing. Journal of the American Medical Association 2002; 287: 1840–1847
   PubMed Web of Science ®Google Scholar
• Andrews G. Placebo response in depression: bane of research, boon to therapy. British Journal of Psychiatry 2001; 178: 192–194
   PubMed Web of Science ®Google Scholar
• Brown W A, Dornseif B E, Wernicke J F. Placebo response in depression: a search for predictors. Psychiatry Research 1988; 26: 259–264
   PubMed Web of Science ®Google Scholar
• Fairchild C J, Rush A J, Vasavada N., Giles D E, Khatami M. Which depressions respond to placebo?. Psychiatry Research 1986; 18: 217–226
   PubMed Web of Science ®Google Scholar
• Tedlow J., Fava M., Uebelacker L., Nierenberg A A, Alpert J E, Rosenbaum J. Outcome definitions and predictors in depression. Psychotherapy and Psychosomatics 1998; 67: 266–270
   PubMed Web of Science ®Google Scholar
• Ramana R. Remission and relapse in major depression: a two-year prospective follow-up study. Psychological Medicine 1995; 25: 1161–1170
   PubMed Web of Science ®Google Scholar
• Coryell W., Keller M., Scheftner W A. Outcome of patients with chronic affective disorder: a five-year follow-up. American Journal of Psychiatry 1990; 147: 1627–1633
   PubMed Web of Science ®Google Scholar
• Westen D., Morrison K. A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. Journal of Consulting and Clinical Psychology 2001; 69: 875–899
   PubMed Web of Science ®Google Scholar
• Howard K I, Moras K., Brill P B, Martinovich Z., Lutz W. Evaluation of psychotherapy: efficacy, effectiveness, and patient progress. American Psychologist 1996; 51: 1059–1064
   PubMed Web of Science ®Google Scholar
• Goldfried M R, Wolfe B E. Toward a more clinically valid approach to therapy research. Journal of Consulting and Clinical Psychology 1998; 66: 143–150
   PubMed Web of Science ®Google Scholar
• Zinbarg R E. The DSM-IV field trial for mixed anxiety-depression. American Journal of Psychiatry 1990; 151: 1153–1162
   Google Scholar
• McGrath P J, Rabkin J G, Stewart J W, et al. Response to phenelzine and imipramine in placebo nonresponders with atypical depression: a new application of the crossover design. Archives of General Psychiatry 1991; 48: 319–323
   PubMed Web of Science ®Google Scholar
• Klein D F, Thase M E, Endicott J., et al. Improving clinical trials: American society of clinical psychopharmacology recommendations. Archives of General Psychiatry 2002; 59: 272–278
   PubMed Web of Science ®Google Scholar
• Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. British Medical Journal 1948; 2: 769–782
   PubMedGoogle Scholar
• Hampton J. Evidence-based medicine, opinion-based medicine, and real-world medicine. Perspectives in Biology and Medicine 2002; 45: 549–568
   PubMed Web of Science ®Google Scholar
• Donoghue J., Hylan T R. Antidepressant use in clinical practice: Efficacy versus effectiveness. British Journal of Psychiatry 2001; 179: s9–s17
   PubMed Web of Science ®Google Scholar